Mukherjee Sromona D, Suryavanshi Mangesh, Knight John, Lange Dirk, Miller Aaron W
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
Department of Urology, University of Alabama at Birmingham, Birmingham, Alabama.
mSphere. 2025 Jun 25;10(6):e0091324. doi: 10.1128/msphere.00913-24. Epub 2025 May 13.
The gut microbiota is critical for neutralizing dietary toxins. Oxalate is a toxin commonly produced by plants to deter herbivory and is widely consumed in the human diet. Excess levels of systemic or urinary oxalate increase risk of multiple urologic and cardiometabolic diseases. The current study employed multiple amplicon-based and shotgun metagenomic methodologies, alongside comparative phylogenetic analyses, to interrogate evolutionary radiation surrounding microbial oxalate degradation within the human gut microbiome. In conservative genome-based estimates, over 30% of gut microbial species harbored at least one oxalate-handling gene, with the specific pathways used dependent on bacterial phylum. Co-occurrence analyses revealed interactions between specialist genes that can metabolize oxalate or its by-products, but not multi-functional genes that can act in more than one oxalate-related pathway. Specialization was rare at the genome level. Amplicon-based metagenomic sequencing of the oxalate-degrading gene, formyl-CoA transferase (), coupled with molecular clock phylogenetic analyses are indicative of rapid evolutionary divergence, constrained by phylum. This was corroborated by paired analyses of non-synonymous to synonymous substitutions (dN/dS ratios), which pointed toward neutral to positive selection. Sequence similarity network analyses of sequences suggest extensive horizontal gene transferring has occurred with the gene, which may have facilitated rapid divergence. The gene was primarily allocated to the Pseudomonodota phylum, particularly the genus, which is a species capable of utilizing oxalate as a sole carbon and energy source. Collectively evidence provides strong support that, for oxalate metabolism, evolutionary selection occurs at the gene level, through horizontal gene transfer, rather than at the species level.IMPORTANCEA critical function of the gut microbiota is to neutralize dietary toxins, such as oxalate, which is highly prevalent in plant-based foods and is not degraded by host enzymes. However, little is known about the co-evolutionary patterns of plant toxins and the mammalian gut microbiota, which are expected to exhibit features of an evolutionary arms race. In the current work, we present molecular evidence that microbial genes for oxalate degradation are highly prevalent in humans, potentially driven by extensive horizontal gene transfer events. Phylogenetic analyses reveal that oxalate-degrading genes are under a positive selection pressure and have historically undergone rapid diversification events, which has led to diverse ecological strategies for handling oxalate by gut bacteria. Collectively, data shed light on potential evolutionary relationships between the diet and the gut microbiota that occur relatively independently of the mammalian host.
肠道微生物群对于中和膳食毒素至关重要。草酸盐是植物通常产生的一种毒素,用于阻止食草动物,并且在人类饮食中广泛存在。全身或尿液中草酸盐水平过高会增加多种泌尿系统和心脏代谢疾病的风险。当前的研究采用了多种基于扩增子和鸟枪法宏基因组学方法,以及比较系统发育分析,来探究人类肠道微生物群中微生物草酸盐降解的进化辐射。基于保守基因组的估计,超过30%的肠道微生物物种至少含有一个草酸盐处理基因,所使用的具体途径取决于细菌门类。共现分析揭示了能够代谢草酸盐或其副产物的特异性基因之间的相互作用,但不是能够在多种草酸盐相关途径中发挥作用的多功能基因。在基因组水平上专业化很少见。基于扩增子的草酸盐降解基因甲酰辅酶A转移酶()的宏基因组测序,结合分子钟系统发育分析,表明在门类的限制下存在快速进化分歧。这通过非同义替换与同义替换的配对分析(dN/dS比率)得到了证实,该分析指向中性到正选择。对序列的序列相似性网络分析表明,与该基因发生了广泛的水平基因转移,这可能促进了快速分歧。该基因主要分配到假单胞菌门,特别是属,该属是一种能够利用草酸盐作为唯一碳源和能源的物种。总体而言,证据有力地支持了对于草酸盐代谢,进化选择发生在基因水平,通过水平基因转移,而不是在物种水平。重要性肠道微生物群的一个关键功能是中和膳食毒素,如草酸盐,草酸盐在植物性食物中高度普遍且不会被宿主酶降解。然而,关于植物毒素与哺乳动物肠道微生物群的共同进化模式知之甚少,预计它们会表现出进化军备竞赛的特征。在当前的工作中,我们提供了分子证据,表明草酸盐降解的微生物基因在人类中高度普遍,可能是由广泛的水平基因转移事件驱动的。系统发育分析表明,草酸盐降解基因处于正选择压力之下,并且历史上经历了快速多样化事件,这导致了肠道细菌处理草酸盐的多种生态策略。总体而言,数据揭示了饮食与肠道微生物群之间相对独立于哺乳动物宿主发生的潜在进化关系。
Cochrane Database Syst Rev. 2022-5-20
Cochrane Database Syst Rev. 2008-7-16
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2022-9-20
Cochrane Database Syst Rev. 2020-10-19
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2017-12-22
Cochrane Database Syst Rev. 2018-2-6
Nat Rev Microbiol. 2023-9
Nat Rev Nephrol. 2023-2
FEMS Microbiol Ecol. 2022-2-10
Mol Biol Evol. 2021-6-25
Nat Rev Nephrol. 2021-6